Policy & Regulation
Vera Therapeutics Launches with USD 80m Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease
19 January 2021 - - US-based biotechnology company Vera Therapeutics, Inc has launched backed by USD 80m Series C financing led by Abingworth LLP, the company said.

Other invest...
Transgene, BioInvent Receive Approval from ANSM to Proceed with Phase I/IIa Trial of Anti-CTLA4-armed Oncolytic Virus BT-001 in Solid Tumors
19 January 2021 - - France-based biotechnology company Transgene (Euronext Paris: TNG) has received approval from the French National Agency for the Safety of Medicines and Health Products to proceed ...
Ixaka Launches as an Integrated Cell and Gene Therapy Company
19 January 2021 - - UK-based integrated cell and gene therapy company Ixaka Ltd has launched, the company said.

The company's shareholders have funded the business with over GBP 40m ...
Enhertu Approved in the US for the Treatment of Patients with Previously Treated HER2-Positive Advanced Gastric Cancer
19 January 2021 - - British-Swedish pharmaceutical and biopharmaceutical company AstraZeneca (OTC: AZNCF) and Japan-based pharmaceutical company Daiichi Sankyo Company, Ltd's (OTC: DSKYF) Enhertu...
First Patient Dosed in Phase II Trial of Debiopharm's Antiviral Alisporivir Against Covid-19
19 January 2021 - - The first patient dosed in an investigator-initiated, randomized phase II, open-label clinical trial for Switzerland-based biopharmaceutical company Debiopharm's antiviral ali...
Metrion Biosciences and LifeArc extend neuroscience-Ion channel drug discovery collaboration for a further 12 months
19 January 2021 - Drug discovery company Metrion Biosciences Limited reported on Monday a 12-month extension of its neuroscience drug discovery collaboration with LifeArc, a leading UK independent med...